FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2013/04/003587 [Registered on: 26/04/2013] Trial Registered Retrospectively
Last Modified On: 25/04/2013
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   STUDY OF NAIL BED ARTERIAL CIRCULATION IN DIABETIC PATIENTS AND ITS CORRELATION WITH COMPLICATIONS. 
Scientific Title of Study   Study of changes in acral microcirculation in Diabetes Mellitus and its correlation with microvascular complications. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rajesh Jain 
Designation  Dr 
Affiliation  DM Post doctoral Trainee Seth Sukhlal Kirmani Memorial Hospital SSKM Hospital 
Address  Department of Endocrinology and Metabolism Roland Rossbuilding 244 AJC Bose road Institute of Post Graduate Medical Education and Research.

Kolkata
WEST BENGAL
700020
India 
Phone  9903560769  
Fax    
Email  docrajeshjain@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Subhankar Chowdhury 
Designation  Professor 
Affiliation  Professor and Head 
Address  department of endocrinology and metabolism roland ross building 244 ajc bose road Institute of Post Graduate Medical Education and Research.

Kolkata
WEST BENGAL
700020
India 
Phone  9831076501  
Fax    
Email  subhankar.chowdhury@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Rajesh Jain 
Designation  Dr 
Affiliation  DM Post doctoral Trainee Seth Sukhlal Kirmani Memorial Hospital SSKM Hospital 
Address  department of endocrinology and metabolism roland ross building 244 ajc bose road Institute of Post Graduate Medical Education and Research.

Kolkata
WEST BENGAL
700020
India 
Phone  9903560769  
Fax    
Email  docrajeshjain@gmail.com  
 
Source of Monetary or Material Support  
RSSDI- Research society for the study of diabetes in india West Bengal Chapter Department of endocrinology and metabolism Roland Ross Building 4th floor SSKM Hospital Kolkata 
 
Primary Sponsor  
Name  RSSDI 
Address  RSSDI Secretariat Department of Medicine Division of Endocrinology and Metabolism University College of Medical Sciences Dilshad Garden, Delhi 110 095 INDIA  
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Rajesh Jain  SSKM Hospital  Department of endocrinology 244 AJC bose road kolkata Kolkata
Kolkata
WEST BENGAL 
9903560769

docrajeshjain@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IPGMER research oversight committee, Kolkata, west bengal   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Diabetes,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients attending diabetic clinic or endocrine out patient department (OPD) services of SSKM Hospital and IPGME& R will be considered. Patients >30 years and <60 years of age will be considered 
 
ExclusionCriteria 
Details  Exclusion criteria include patients with clinical signs of acral ischemic gangrene, Takayasu’s arteritis, autoimmune disorders, clubbing and skin infections including fungal paronychia. Patients with pregnancy would be excluded 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Peak systolic velocity (PSV), End diastolic velocity (EDV), Resistance Index (RI), percentage area of vascularity   3 months 
 
Secondary Outcome  
Outcome  TimePoints 
glycemic status  3 months 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   08/04/2013 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Diabetes mellitus (DM) is one of the most common endocrine diseases, characterized by an increase in plasma glucose. The most prevalent form of diabetes is type 2 diabetes (T2D), currently affecting more than 300 million people worldwide1 Furthermore, DM is not only a disease complicating human health worldwide, but also a substantial burden to health care systems, especially in developing countries. Acral ischemic gangrene is a common and serious complication of type 2 DM and is one of the main causes of mortality and disability associated with DM2. Its pathological basis is a vascular defect caused by DM. The pathogenesis of this vascular defect involves vascular endothelial cell damage, accumulation of glycation end products (Advanced Glycation End products, AGEs), and proliferation of smooth muscle cell or matrix due to chronically elevated levels of glucose, cholesterol, and insulin. All these factors lead to arterial reconstruction. Furthermore, extensive micro-thrombosis develops as a result of hypercoagulability, and nonsymmetric stenosis or occlusion of peripheral vessels emerge at terminal stages. Early vascular lesions occur early on and usually impact arterioles without any clinical symptoms. Importantly, these early arteriolar lesions occur prior to clinical manifestations of DM, and are potentially reversible at this stage. When disease progresses, pathological changes in arterioles become irreversible due to persistent metabolic disorders, and result in serious complications such as acral ischemic gangrene3, diabetic nephropathy4 etc. An early intervention can prevent or delay progressive development of arteriolar vascular disease5, 6 .Therefore, early and proper assessment of acral microcirculation is crucial for reducing the likelihood of severe complications. Unfortunately, evaluation of microcirculation disturbance in the acra, particularly in patients with DM, has been hampered by the lack of proper imaging parameters.  It is likely that microcirculatory disturbances of varying degree occur in early stages of the disease. Microcirculatory disturbances include alteration of the microvascular flow and metabolic changes of tissues and cells due to pathological change of microvessels, remodeling of arterioles, and high blood coagulation. Common methods of clinical detection include a nail fold microcirculation analysis, fluorescence microscopic technique, and hemorheologic test7 The blood supply in the nail bed reflects not only the physiologic and pathological condition of the nail bed itself, but is also closely associated with the general pathological condition. For this reason, the nail bed is often used to assess the microcirculation of the body. A study demonstrates that abnormal microcirculation of digital arterioles exists in most patients with DM prior to ischemic acral gangrene. The abnormal microcirculation manifested early with hemodynamic changes, decreased blood flow, and increased resistance of arterioles in finger and toe. It was further observed that arterioles of fingers and toes in patients with DM were abnormally distributed, twisted, discontinued, and disarranged8. As disease progresses, the number of arterioles further diminishes. The hemodynamic changes of the finger and toe arterioles in patients with complicated DM (hypertension and/or hyperlipemia) are even more pronounced. This also explains how the metabolic disorder aggravates the disturbance of digital microcirculation. Decreased blood flow and increased blood flow resistance in the diastolic phase were the earliest hemodynamic changes observed in a study8. These changes indicate that arteriolar damage in the early stage of type 2 DM is mainly in the form of decreased vascular elasticity, and that Resistance Index (RI) is a relatively sensitive marker to detect these changes. Furthermore, vascular abnormalities of nail bed arterioles appeared prior to those in pulp arterioles, and this was true for both finger and toe. Therefore, examination of the nail bed arterioles is likely a more sensitive technique to detect early vascular abnormalities and there has been a paucity of studies in this issue and hence we plan a study directly correlating acral vascular changes with microvascular complications.

 

AIMS & OBJECTIVES

The aim of this study is

1.      To compare the changes in vascularity in nail bed and digital arterioles in diabetic patients with microvascular complications, with diabetic patients without microvascular complications and also compared with age and sex matched controls without diabetes.

2.      To assess whether these vascular changes can be used as a marker of microvascular complications.

 

MATERIAL & METHODS

Patients attending diabetic clinic or endocrine out patient department (OPD) services of SSKM Hospital and IPGME& R will be considered. Patients >30 years and <60 years of age will be considered. Study subjects will be divided into 3 groups. Each group will comprise of 30 study subjects. Group 1 would include diabetic patients with at least one of the microvascular complications, group 2 to include diabetic patients without microvascular complications and group 3 involve non diabetic age and sex matched controls.  Duration of diabetes will be noted for all the patients. Exclusion criteria include patients with clinical signs of acral ischemic gangrene, Takayasu’s arteritis, autoimmune disorders, clubbing and skin infections including fungal paronychia. Patients with pregnancy would be excluded. The initially considered patients would be screened for microvascular complications, dilated fundus examination for retinopathy, spot urine albumin creatinine ratio(ACR) for nephropathy and vibration pressure threshold (VPT) and monofilament(MFT) for neuropathy and all patients would undergo detailed clinical examination. Lipid profile, serum creatinine, HbA1c, uric acid, electrolytes, and hemogram would be estimated in all patients.

 

The patients would be explained about the study and only those who give informed written consent would be included in the final study. Clearance from the Institutional Ethics committee will be obtained before the study initiation. In the finally included patients in the study ultrasound Doppler of the nail bed arterioles and digital arterioles of the middle finger of the non dominant hand will be done using a 18 MHz linear transducer,9 With the use of colour and power colour Doppler blood flow will be studied and Peak systolic velocity (PSV), End diastolic velocity (EDV), Resistance Index (RI), percentage area of vascularity will be calculated in all the study subjects. A temperature of 20 to 25 degree Celsius will be maintained at Doppler site and patients will be there for at least 30 minutes to negate temperature bias. A master chart depicting all the values will be made for the final statistical analysis.

 

Statistical Analysis

ANOVA unpaired t- test will be used for analysis of continuous variables and all results of continuous variables will be expressed as mean ± SD.

References:

 

  1. IDF diabetes atlas. 4th edition. International Diabetes Federation; 2009. Available at: http://www.diabetesatlas.org/.

 

  1. King H, Keuky L, Seng S, Khun T, Roglic G, Pinget M. Diabetes and associated disorders in Cambodia: Two epidemiological surveys. Lancet: 2005:366:1633–1639

 

  1. Alnaeb M.E, Crabtree V.P, Boutin A, Mikhailidis D.P, Seifalian A. M, Hamilton G. Prospective assessment of lower-extremity peripheral arterial disease in diabetic patients using a novel automated optical device. Angiology: 2007: 58: 579–585

 

  1. Wolf G, Ritz E Diabetic nephropathy in type 2 diabetes prevention and patient management. Journal of the American Society of Nephrology: 2003: 14: 1396–1405.

 

  1. Sachidanandam K, Hutchinson J.R, Elgebaly M. M, et al.  Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: Link to endothelin-1. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology: 2009: 296: R952–R959.

 

  1. Vinik A.I, Vinik E. Prevention of the complications of diabetes. American Journal of Managed Care: 2003: 9: S63–S80.

 

  1. Vigilance J. E, Reid H. L Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease. Journal of Diabetes and Its Complications; 2008: 22: 210–216.

 

  1. Fang Ma Baozhen Zhao Huiping Zhang Wei-Ping Li Yuan-Yuan Liu Yuan-Yuan Dang etal, Usefulness of Enhanced Power Doppler Imaging in Monitoring Acral Microcirculation in Type 2 Diabetes Mellitus and its Complications Cell Biochem Biophys ;2011: 61:435–441 

 

 

  1. Cecchini A, Montella A, Ena P, Meloni GB, Mazzarello V. Ultrasound anatomy of normal nails unit with 18 mhz linear transducer.Ital J Anat Embryol.;2009:114(4):137-44.

 
Close